Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow Print PDF (1235K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (109)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Rhee, S.-Y.
Right arrow Articles by Shafer, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rhee, S.-Y.
Right arrow Articles by Shafer, R. W.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 2003, Vol. 31, No. 1 298-303
© 2003 Oxford University Press

Human immunodeficiency virus reverse transcriptase and protease sequence database

Soo-Yon Rhee, Matthew J. Gonzales, Rami Kantor, Bradley J. Betts, Jaideep Ravela and Robert W. Shafer*

Division of Infectious Diseases, Department of Medicine, Stanford University, Stanford, CA 94305, USA

*To whom correspondence should be addressed Tel: +1 6507252946; Fax: +1 6507238596; Email: rshafer{at}stanford.edu

ABSTRACT

The HIV reverse transcriptase and protease sequence database is an on-line relational database that catalogues evolutionary and drug-related sequence variation in the human immunodeficiency virus (HIV) reverse transcriptase (RT) and protease enzymes, the molecular targets of antiretroviral therapy (http://hivdb.stanford.edu). The database contains a compilation of nearly all published HIV RT and protease sequences, including submissions to GenBank, sequences published in journal articles and sequences of HIV isolates from persons participating in clinical trials. Sequences are linked to data about the source of the sequence, the antiretroviral drug treatment history of the person from whom the sequence was obtained and the results of in vitro drug susceptibility testing. Sequence data on two new molecular targets of HIV drug therapy—gp41 (cell fusion) and integrase—will be added to the database in 2003.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 BioinformaticsHome page
J. Bogojeska, A. Alexa, A. Altmann, T. Lengauer, and J. Rahnenfuhrer
Rtreemix: an R package for estimating evolutionary pathways and genetic progression scores
Bioinformatics, October 15, 2008; 24(20): 2391 - 2392.
[Abstract] [Full Text] [PDF]

Home page
 BioinformaticsHome page
M. Rosen-Zvi, A. Altmann, M. Prosperi, E. Aharoni, H. Neuvirth, A. Sonnerborg, E. Schulter, D. Struck, Y. Peres, F. Incardona, et al.
Selecting anti-HIV therapies based on a variety of genomic and clinical factors
Bioinformatics, July 1, 2008; 24(13): i399 - i406.
[Abstract] [Full Text] [PDF]

Home page
 BioinformaticsHome page
Y. Liu, E. Eyal, and I. Bahar
Analysis of correlated mutations in HIV-1 protease using spectral clustering
Bioinformatics, May 15, 2008; 24(10): 1243 - 1250.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
E. S. Margerison, M. Maguire, D. Pillay, P. Cane, and R. C. Elston
The HIV-1 protease substitution K55R: a protease-inhibitor-associated substitution involved in restoring viral replication
J. Antimicrob. Chemother., April 1, 2008; 61(4): 786 - 791.
[Abstract] [Full Text] [PDF]

Home page
 BioinformaticsHome page
F. M. Graziano, S. Y. Kettoola, J. M. Munshower, J. T. Stapleton, and G. J. Towfic
Effect of spatial distribution of T-Cells and HIV load on HIV progression
Bioinformatics, March 15, 2008; 24(6): 855 - 860.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
A. F. Y. Poon, S. L. Kosakovsky Pond, D. D. Richman, and S. D. W. Frost
Mapping Protease Inhibitor Resistance to Human Immunodeficiency Virus Type 1 Sequence Polymorphisms within Patients
J. Virol., December 15, 2007; 81(24): 13598 - 13607.
[Abstract] [Full Text] [PDF]

Home page
 BioinformaticsHome page
H. Saigo, T. Uno, and K. Tsuda
Mining complex genotypic features for predicting HIV-1 drug resistance
Bioinformatics, September 15, 2007; 23(18): 2455 - 2462.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
V. von Wyl, S. Yerly, J. Boni, P. Burgisser, T. Klimkait, M. Battegay, H. Furrer, A. Telenti, B. Hirschel, P. L. Vernazza, et al.
Emergence of HIV-1 Drug Resistance in Previously Untreated Patients Initiating Combination Antiretroviral Treatment: A Comparison of Different Regimen Types
Arch Intern Med, September 10, 2007; 167(16): 1782 - 1790.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
H. E. Klei, K. Kish, P.-F. M. Lin, Q. Guo, J. Friborg, R. E. Rose, Y. Zhang, V. Goldfarb, D. R. Langley, M. Wittekind, et al.
X-Ray Crystal Structures of Human Immunodeficiency Virus Type 1 Protease Mutants Complexed with Atazanavir
J. Virol., September 1, 2007; 81(17): 9525 - 9535.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
J. H. Brehm, D. Koontz, J. D. Meteer, V. Pathak, N. Sluis-Cremer, and J. W. Mellors
Selection of Mutations in the Connection and RNase H Domains of Human Immunodeficiency Virus Type 1 Reverse Transcriptase That Increase Resistance to 3'-Azido-3'-Dideoxythymidine
J. Virol., August 1, 2007; 81(15): 7852 - 7859.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
C. Hoffmann, N. Minkah, J. Leipzig, G. Wang, M. Q. Arens, P. Tebas, and F. D. Bushman
DNA bar coding and pyrosequencing to identify rare HIV drug resistance mutations
Nucleic Acids Res., July 26, 2007; 35(13): e91 - e91.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
S. G. Parisi, C. Boldrin, M. Cruciani, G. Nicolini, I. Cerbaro, V. Manfrin, F. Dal Bello, E. Franchin, M. Franzetti, M. C. Rossi, et al.
Both Human Immunodeficiency Virus Cellular DNA Sequencing and Plasma RNA Sequencing Are Useful for Detection of Drug Resistance Mutations in Blood Samples from Antiretroviral-Drug-Naive Patients
J. Clin. Microbiol., June 1, 2007; 45(6): 1783 - 1788.
[Abstract] [Full Text] [PDF]

Home page
 Mol Biol EvolHome page
C. Seoighe, F. Ketwaroo, V. Pillay, K. Scheffler, N. Wood, R. Duffet, M. Zvelebil, N. Martinson, J. McIntyre, L. Morris, et al.
A Model of Directional Selection Applied to the Evolution of Drug Resistance in HIV-1
Mol. Biol. Evol., April 1, 2007; 24(4): 1025 - 1031.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
C. Pan, J. Kim, L. Chen, Q. Wang, and C. Lee
The HIV positive selection mutation database
Nucleic Acids Res., January 12, 2007; 35(suppl_1): D371 - D375.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
N. A. Margot, J. M. Waters, and M. D. Miller
In Vitro Human Immunodeficiency Virus Type 1 Resistance Selections with Combinations of Tenofovir and Emtricitabine or Abacavir and Lamivudine
Antimicrob. Agents Chemother., December 1, 2006; 50(12): 4087 - 4095.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S.-Y. Rhee, J. Taylor, G. Wadhera, A. Ben-Hur, D. L. Brutlag, and R. W. Shafer
Genotypic predictors of human immunodeficiency virus type 1 drug resistance
PNAS, November 14, 2006; 103(46): 17355 - 17360.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
K. B. Turner, N. A. Hagan, and D. Fabris
Inhibitory effects of archetypical nucleic acid ligands on the interactions of HIV-1 nucleocapsid protein with elements of {Psi}-RNA
Nucleic Acids Res., March 6, 2006; 34(5): 1305 - 1316.
[Abstract] [Full Text] [PDF]

Home page
 BioinformaticsHome page
M. Rabinowitz, L. Myers, M. Banjevic, A. Chan, J. Sweetkind-Singer, J. Haberer, K. McCann, and R. Wolkowicz
Accurate prediction of HIV-1 drug response from the reverse transcriptase and protease amino acid sequences using sparse models created by convex optimization
Bioinformatics, March 1, 2006; 22(5): 541 - 549.
[Abstract] [Full Text] [PDF]

Home page
 BioinformaticsHome page
N. Beerenwinkel, T. Sing, T. Lengauer, J. Rahnenfuhrer, K. Roomp, I. Savenkov, R. Fischer, D. Hoffmann, J. Selbig, K. Korn, et al.
Computational methods for the design of effective therapies against drug resistant HIV strains
Bioinformatics, November 1, 2005; 21(21): 3943 - 3950.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
M. A. Winters and T. C. Merigan
Insertions in the Human Immunodeficiency Virus Type 1 Protease and Reverse Transcriptase Genes: Clinical Impact and Molecular Mechanisms
Antimicrob. Agents Chemother., July 1, 2005; 49(7): 2575 - 2582.
[Full Text] [PDF]

Home page
 Genome ResHome page
E. A. Stone and A. Sidow
Physicochemical constraint violation by missense substitutions mediates impairment of protein function and disease severity
Genome Res., July 1, 2005; 15(7): 978 - 986.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
R. W. Shafer and J. M. Schapiro
Drug resistance and antiretroviral drug development
J. Antimicrob. Chemother., June 1, 2005; 55(6): 817 - 820.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
J. P. Casazza, M. R. Betts, B. J. Hill, J. M. Brenchley, D. A. Price, D. C. Douek, and R. A. Koup
Immunologic Pressure within Class I-Restricted Cognate Human Immunodeficiency Virus Epitopes during Highly Active Antiretroviral Therapy
J. Virol., March 15, 2005; 79(6): 3653 - 3663.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
E. Johnston, M. A. Winters, S.-Y. Rhee, T. C. Merigan, C. A. Schiffer, and R. W. Shafer
Association of a Novel Human Immunodeficiency Virus Type 1 Protease Substrate Cleft Mutation, L23I, with Protease Inhibitor Therapy and In Vitro Drug Resistance
Antimicrob. Agents Chemother., December 1, 2004; 48(12): 4864 - 4868.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
S.-Y. Rhee, T. Liu, J. Ravela, M. J. Gonzales, and R. W. Shafer
Distribution of Human Immunodeficiency Virus Type 1 Protease and Reverse Transcriptase Mutation Patterns in 4,183 Persons Undergoing Genotypic Resistance Testing
Antimicrob. Agents Chemother., August 1, 2004; 48(8): 3122 - 3126.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
Z. Grossman, E. E. Paxinos, D. Averbuch, S. Maayan, N. T. Parkin, D. Engelhard, M. Lorber, V. Istomin, Y. Shaked, E. Mendelson, et al.
Mutation D30N Is Not Preferentially Selected by Human Immunodeficiency Virus Type 1 Subtype C in the Development of Resistance to Nelfinavir
Antimicrob. Agents Chemother., June 1, 2004; 48(6): 2159 - 2165.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
Y. Gao, E. Paxinos, J. Galovich, R. Troyer, H. Baird, M. Abreha, C. Kityo, P. Mugyenyi, C. Petropoulos, and E. J. Arts
Characterization of a Subtype D Human Immunodeficiency Virus Type 1 Isolate That Was Obtained from an Untreated Individual and That Is Highly Resistant to Nonnucleoside Reverse Transcriptase Inhibitors
J. Virol., May 15, 2004; 78(10): 5390 - 5401.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
L. Chen, A. Perlina, and C. J. Lee
Positive Selection Detection in 40,000 Human Immunodeficiency Virus (HIV) Type 1 Sequences Automatically Identifies Drug Resistance and Positive Fitness Mutations in HIV Protease and Reverse Transcriptase
J. Virol., April 1, 2004; 78(7): 3722 - 3732.
[Abstract] [Full Text] [PDF]

Home page
 Protein Sci.Home page
A. L. Perryman, J.-H. Lin, and J. A. McCammon
HIV-1 protease molecular dynamics of a wild-type and of the V82F/I84V mutant: Possible contributions to drug resistance and a potential new target site for drugs
Protein Sci., April 1, 2004; 13(4): 1108 - 1123.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
C. E. Cases-Gonzalez and L. Menendez-Arias
Increased G->A Transition Frequencies Displayed by Primer Grip Mutants of Human Immunodeficiency Virus Type 1 Reverse Transcriptase
J. Virol., January 15, 2004; 78(2): 1012 - 1019.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
N. Beerenwinkel, M. Daumer, M. Oette, K. Korn, D. Hoffmann, R. Kaiser, T. Lengauer, J. Selbig, and H. Walter
Geno2pheno: estimating phenotypic drug resistance from HIV-1 genotypes
Nucleic Acids Res., July 1, 2003; 31(13): 3850 - 3855.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.